HealthStream (NASDAQ:HSTM) Upgraded to “Buy” at Wall Street Zen
by Teresa Graham · The Cerbat GemHealthStream (NASDAQ:HSTM – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.
Several other research analysts also recently commented on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of HealthStream in a report on Wednesday, October 8th. Canaccord Genuity Group lowered their price objective on HealthStream from $29.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, August 7th. One analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, HealthStream presently has an average rating of “Hold” and a consensus target price of $28.00.
Check Out Our Latest Research Report on HealthStream
HealthStream Stock Performance
NASDAQ HSTM traded down $0.12 during trading hours on Friday, hitting $24.65. The company had a trading volume of 177,383 shares, compared to its average volume of 181,502. The firm has a market capitalization of $730.65 million, a price-to-earnings ratio of 36.79, a PEG ratio of 3.08 and a beta of 0.43. HealthStream has a 52 week low of $24.07 and a 52 week high of $34.24. The firm has a 50 day simple moving average of $27.26 and a 200 day simple moving average of $27.69.
HealthStream (NASDAQ:HSTM – Get Free Report) last announced its quarterly earnings results on Monday, November 3rd. The technology company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.03. HealthStream had a net margin of 6.89% and a return on equity of 5.70%. The firm had revenue of $76.47 million for the quarter, compared to the consensus estimate of $75.52 million. HealthStream has set its FY 2025 guidance at EPS. On average, research analysts forecast that HealthStream will post 0.63 earnings per share for the current year.
Insider Activity
In related news, EVP Kevin P. O’hara sold 2,000 shares of the company’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $27.97, for a total value of $55,940.00. Following the completion of the transaction, the executive vice president directly owned 17,137 shares in the company, valued at approximately $479,321.89. The trade was a 10.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 20.50% of the company’s stock.
Institutional Investors Weigh In On HealthStream
Several hedge funds have recently added to or reduced their stakes in the company. Robeco Institutional Asset Management B.V. boosted its holdings in shares of HealthStream by 162.1% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 380,604 shares of the technology company’s stock worth $10,531,000 after purchasing an additional 235,382 shares in the last quarter. JPMorgan Chase & Co. lifted its position in HealthStream by 302.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock worth $6,860,000 after buying an additional 186,231 shares during the last quarter. Copeland Capital Management LLC boosted its stake in HealthStream by 15.6% in the second quarter. Copeland Capital Management LLC now owns 882,950 shares of the technology company’s stock worth $24,431,000 after buying an additional 119,260 shares in the last quarter. Qube Research & Technologies Ltd grew its position in HealthStream by 77.3% during the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company’s stock valued at $6,972,000 after acquiring an additional 109,883 shares during the last quarter. Finally, Bridgeway Capital Management LLC bought a new position in HealthStream during the first quarter valued at approximately $3,228,000. Institutional investors own 69.58% of the company’s stock.
HealthStream Company Profile
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Featured Articles
- Five stocks we like better than HealthStream
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Basic Materials Stocks Investing
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- How to invest in marijuana stocks in 7 steps
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?